DexCom, Inc. (DXCM)

DXCM Balance Sheet

Assets, liabilities, and equity analysis

DXCM Quarterly Balance Sheet (USD)

Quarterly Report	TTM	03/31/2026	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024	09/30/2024	06/30/2024
Total Current Assets	4.332B	4.332B	4.033B	5.220B	5.030B	4.554B	4.301B	4.263B	4.848B
Cash & Cash Equivalents	1.118B	1.118B	917.700M	1.836B	1.159B	904.900M	606.100M	621.200M	939.200M
Short-Term Investments	1.297B	1.297B	1.081B	1.486B	1.770B	1.796B	1.973B	1.871B	2.182B
Cash & Short-Term Investments	2.415B	2.415B	1.999B	3.322B	2.929B	2.701B	2.579B	2.492B	3.121B
Accounts Receivable	1.105B	1.105B	1.290B	1.169B	1.377B	1.170B	1.034B	1.034B	998.700M
Inventory	693.600M	693.600M	629.100M	604.100M	570.700M	538.200M	542.600M	586.300M	570.300M
Total Assets	6.633B	6.633B	6.340B	7.500B	7.327B	6.752B	6.484B	6.354B	6.799B
Property, Plant & Equipment	1.633B	1.633B	1.637B	1.525B	1.514B	1.424B	1.403B	1.386B	1.254B
Goodwill	24.200M	24.200M	24.200M	24.100M	24.100M	23.100M	22.800M	23.800M	23.300M
Intangible Assets	62.600M	62.600M	70.800M	79.000M	87.200M	95.200M	103.400M	106.200M	114.500M
Long-Term Investments	219.500M	219.500M	218.000M	216.900M	115.800M	115.800M	119.300M	46.300M	43.600M
Total Current Liabilities	2.224B	2.224B	2.143B	3.336B	3.309B	3.037B	2.932B	1.734B	1.722B
Accounts Payable	394.300M	394.300M	344.300M	451.500M	472.000M	432.000M	345.300M	326.600M	307.000M
Short-Term Debt	0.00	0.00	0.00	1.207B	1.206B	1.205B	1.204B	0.00	0.00
Total Liabilities	3.676B	3.676B	3.594B	4.774B	4.754B	4.485B	4.382B	4.375B	4.365B
Long-Term Debt	1.242B	1.242B	1.241B	1.240B	1.239B	1.238B	1.237B	2.440B	2.438B
Total Debt	1.385B	1.385B	1.390B	2.576B	2.579B	2.583B	2.587B	2.591B	2.594B
Net Debt (Cash)	266.600M	266.600M	472.000M	739.900M	1.420B	1.678B	1.981B	1.970B	1.655B
Total Shareholders' Equity	2.957B	2.957B	2.746B	2.726B	2.573B	2.267B	2.103B	1.979B	2.434B
Common Stock	400K	400K	400K	400K	400K	400K	400K	400K	400K
Retained Earnings	2.633B	2.633B	2.434B	2.167B	1.883B	1.703B	1.598B	1.446B	1.311B
Current Ratio	1.95	1.95	1.88	1.56	1.52	1.50	1.47	2.46	2.82
Debt to Equity Ratio	0.47	0.47	0.51	0.94	1.00	1.14	1.23	1.31	1.07

DXCM Annual Balance Sheet (USD)

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Total Current Assets	4.033B	4.301B	4.426B	3.669B	3.684B	3.425B	1.969B	1.700B
Cash & Cash Equivalents	917.700M	606.100M	566.300M	642.300M	1.053B	817.600M	446.200M	1.137B
Short-Term Investments	1.081B	1.973B	2.158B	1.814B	1.679B	1.890B	1.087B	248.600M
Cash & Short-Term Investments	1.999B	2.579B	2.724B	2.456B	2.731B	2.708B	1.533B	1.386B
Accounts Receivable	1.290B	1.034B	987.500M	752.200M	516.600M	428.500M	286.300M	226.700M
Inventory	629.100M	542.600M	559.600M	306.700M	357.300M	234.700M	119.800M	70.700M
Total Assets	6.340B	6.484B	6.264B	5.392B	4.933B	4.290B	2.395B	1.916B
Property, Plant & Equipment	1.637B	1.403B	1.185B	1.136B	889.900M	608.600M	392.800M	183.100M
Goodwill	24.200M	22.800M	25.200M	25.700M	26.500M	19.300M	18.600M	18.700M
Intangible Assets	70.800M	103.400M	134.500M	173.300M	31.500M	21.400M	0.00	0.00
Long-Term Investments	218.000M	119.300M	38.500M	19.000M	0.00	0.00	0.00	0.00
Total Current Liabilities	2.143B	2.932B	1.556B	1.839B	720.800M	614.100M	360.200M	222.400M
Accounts Payable	344.300M	345.300M	276.400M	237.900M	189.400M	163.300M	102.300M	75.500M
Short-Term Debt	0.00	1.204B	0.00	772.600M	0.00	0.00	0.00	0.00
Total Liabilities	3.594B	4.382B	4.196B	3.260B	2.891B	2.464B	1.512B	1.253B
Long-Term Debt	1.241B	1.237B	2.434B	1.198B	1.982B	1.667B	1.060B	1.010B
Total Debt	1.390B	2.587B	2.594B	2.145B	2.158B	1.839B	1.160B	1.018B
Net Debt (Cash)	472.000M	1.981B	2.028B	1.503B	1.105B	1.022B	713.900M	-119.400M
Total Shareholders' Equity	2.746B	2.103B	2.069B	2.132B	2.042B	1.827B	882.600M	663.300M
Common Stock	400K	400K	400K	400K	400K	100K	100K	100K
Retained Earnings	2.434B	1.598B	1.021B	479.900M	138.700M	-202.100M	-695.700M	-798.900M
Current Ratio	1.88	1.47	2.84	1.99	5.11	5.58	5.47	7.64
Debt to Equity Ratio	0.51	1.23	1.25	1.01	1.06	1.01	1.31	1.53

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About DexCom, Inc.

DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.

San Diego, CA

10,200 employees

www.dexcom.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Jacob Steven Leach

View full financials